Nature Communications (Jan 2018)

ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma

  • Shujun Han,
  • Yibo Ren,
  • Wangxiao He,
  • Huadong Liu,
  • Zhe Zhi,
  • Xinliang Zhu,
  • Tielin Yang,
  • Yu Rong,
  • Bohan Ma,
  • Timothy J. Purwin,
  • Zhenlin Ouyang,
  • Caixia Li,
  • Xun Wang,
  • Xueqiang Wang,
  • Huizi Yang,
  • Yan Zheng,
  • Andrew E. Aplin,
  • Jiankang Liu,
  • Yongping Shao

DOI
https://doi.org/10.1038/s41467-017-02354-x
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 14

Abstract

Read online

In BRAF mutant melanoma, inhibition of ERK1/2 induces FOXD3 and mediates RAF inhibitor resistance. Here, the authors show that ERK1/2 mediated phosphorylation regulates sumoylation of SOX10 which activates FOXD3, and depletion of SOX10 sensitises BRAF mutant melanoma cells to RAF inhibitors.